Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Expanding research and development of naturally-derived psilocybin for future FDA IND-enabling and clinical studies TORONTO, Oct. 20, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announceContinue reading “Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds”

Supreme Cannabis Announces Financial Results for Q4 and Full-year 2020

Established a platform for strong revenue growth and operational efficiency with a strengthened balance sheet 2020 Fourth Quarter Highlights: Increased recreational sales net revenue by 27% quarter-over-quarter and 373% year-over-year, supported by brand expansion and the introduction of Cannabis 2.0 products 36 active retail SKUs listed, with presence in all 10 provinces Completed the firstContinue reading “Supreme Cannabis Announces Financial Results for Q4 and Full-year 2020”

High Tide to Announce Third Quarter 2020 Financial Results

CALGARY, AB – High Tide Inc. (“High Tide” or the “Company“) (CSE: HITI) (OTCQB: HITIF) (Frankfurt: 2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of cannabis lifestyle accessories, will release its financial and operational results for the quarter ended July 31, 2020 before financial markets open on September 16, 2020. High Tide’s third quarter financial andContinue reading “High Tide to Announce Third Quarter 2020 Financial Results”

Canada House Wellness Group Reports Fiscal Year 2020 Results

 -Canada House Wellness Group Inc. (CSE: CHV) (“Canada House” or the “Company“) is pleased to report its financial results for the year ending April 30, 2020. All amounts are stated in thousands of Canadian dollars. Complete details may be found at www.sedar.com. Compared to the 12 months ending April 30, 2019: Revenue was $5,310, an increase of $435 or 9%, comparedContinue reading “Canada House Wellness Group Reports Fiscal Year 2020 Results”

Vireo Health Announces Second Quarter 2020 Financial Results

– Total revenue of $12.2 million increased 70 percent year-over-year – – Operating cost structure continues to improve in-line with management’s expectations – – Development project pipeline positions Company for strong performance improvements in FY21 – — Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO;OTCQX: VREOF), the science-focused, multi-state cannabis company with active operationsContinue reading “Vireo Health Announces Second Quarter 2020 Financial Results”

Curaleaf Reports Record Second Quarter 2020 Financial and Operational Results

Record Second Quarter Pro Forma Revenue(1)(2)of $165.4 Million and Record Second Quarter Managed Revenue(1)of $121.4 Million; Record First Half Managed Revenue(1) of $226.4 Million; Record Adjusted EBITDA(1) of $28.0 Million as Operations Across 17 States Continue to Scale; Completed Closing of the Grassroots Acquisition Expanding Presence to 23 States – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading verticallyContinue reading “Curaleaf Reports Record Second Quarter 2020 Financial and Operational Results”

Eve & Co Announces Financial Results for the Three and Six Months Ended June 30, 2020

 — Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its financial results for the three and six months ended June 30, 2020. The financial statements and management’s discussion and analysis for such period are available on the System for Electronic Document Analysis and Retrieval (“SEDAR”)Continue reading “Eve & Co Announces Financial Results for the Three and Six Months Ended June 30, 2020”

iAnthus Reports Fiscal First Quarter 2020 Financial Results

– iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, reports its financial results for the first quarter ended March 31, 2020. The Company’s condensed interim financial statements for the first quarter ended March 31, 2020 and the related management’s discussion & analysis canContinue reading “iAnthus Reports Fiscal First Quarter 2020 Financial Results”

Zenabis Announces Second Quarter 2020 Financial Results

Q2 2020 consolidated net revenue of $27.4 million compared to $19.9 million in Q1 2020Q2 2020 Adjusted EBITDA of $3.1 million compared to $2.3 million in Q1 2020Q2 2020 gross margin before fair value on cannabis net revenue of 47.4% compared to 39.7% in Q1 2020  -Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) today announced its financial results for the second quarter ended June 30, 2020.Continue reading “Zenabis Announces Second Quarter 2020 Financial Results”